Alector, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Alector, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $2.00K.
- Alector, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $25.00K.
- Alector, Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-03-31 was $1.08M, a 56.54% decline year-over-year.
- Alector, Inc. stock issued during period, value, stock options exercised for the quarter ending 2022-09-30 was $489.00K, a 96.70% decline year-over-year.
- Alector, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $15.00K.
- Alector, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $1.08M, a 64.73% decline from fiscal 2022.
- Alector, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $3.06M, a 89.28% decline from fiscal 2021.
- Alector, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $28.53M, a 350.64% increase from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $2.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $25.00K 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $15.00K 10-K · filed 2026-02-25 | |
| 2023-12-31 | $1.08M 10-K · filed 2025-02-26 | |
| 2023-03-31 | $1.08M 10-Q · filed 2024-11-06 | |
| 2022-12-31 | $3.06M 10-K · filed 2025-02-26 | |
| 2022-09-30 | $489.00K 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $41.00K 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $2.48M 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $28.53M 10-K · filed 2024-02-27 | |
| 2021-09-30 | $14.82M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $1.99M 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $3.87M 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $6.33M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $286.00K 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $2.20M 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $3.22M 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $1.52M 10-K · filed 2022-02-24 | |
| 2019-09-30 | $720.00K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $63.00K 10-Q · filed 2020-11-10 | |
| 2019-03-31 | $5.00K 10-Q · filed 2020-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |